Novartis’s Lutathera To Be First Radiopharmaceutical In Frontline Use After Trial Success

Company Hails ‘Quite Remarkable’ Phase III Results

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.